RDNTHealthcare · Diagnostics & ResearchThe 8 Wall Street analysts covering RadNet, Inc. hold a median 12-month price target of $96 — +19.0% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 42 of 100 as at 4 Nov 2026 — in the lower half.
Consensus tells you what everyone already believes. The model scores RadNet, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Revisions (73): Analysts have, on balance, been raising their forecasts.
Issuance (17): The company has been issuing shares or taking on financing, diluting existing holders.
Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.
The bullish and bearish analyst opinions on RDNT, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
The green dot is the last close — the median target sits +19.0% from it.
Of the 20 most recent actions, 2 moved their price target up and 1 moved it down.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 28 Aug 2026 | Barclays | Maintains | Overweight | $65 → $79 |
| 11 Aug 2026 | Truist Securities | Maintains | Buy | $90 → $94 |
| 11 Aug 2026 | Truist Securities | Maintains | Buy | — |
| 20 May 2026 | Barclays | Maintains | Overweight | $70 → $65 |
| 20 May 2026 | Barclays | Maintains | Overweight | — |
| 21 Apr 2026 | Barclays | Maintains | Overweight | — |
| 9 Jan 2026 | Keybanc | Initiates | Overweight | — |
| 1 Dec 2025 | B. Riley Securities | Maintains | Buy | — |
| 13 Nov 2025 | Barclays | Maintains | Overweight | — |
| 12 Nov 2025 | Truist Securities | Maintains | Buy | — |
| 3 Sept 2025 | Barclays | Maintains | Overweight | — |
| 3 Sept 2025 | Truist Securities | Maintains | Buy | — |
| 13 Aug 2025 | Raymond James | Reiterates | Strong Buy | — |
| 13 June 2025 | B. Riley Securities | Initiates | Buy | — |
| 11 Apr 2025 | Truist Securities | Maintains | Buy | — |
| 24 Mar 2025 | Barclays | Maintains | Overweight | — |
| 5 Mar 2025 | Raymond James | Upgrade | Strong Buy | — |
| 22 Jan 2025 | Barclays | Maintains | Overweight | — |
| 22 Jan 2025 | Truist Securities | Reiterates | Buy | — |
| 15 Jan 2025 | Jefferies | Maintains | Buy | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
RDNT appears in the Radar on the weeks it earns a place.
AI cloud capacity
MSFTAMZNGOOGLORCL
AI chips
NVDAAVGOAMDMU
AI networking and serversIn full
ANETDELLLITECRDO
Data centre power
VRTCEGGEVVST
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Over the twelve months to 4 Nov 2026, RadNet, Inc. returned +2.3% against +14.8% for the S&P 500, dividends included.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 1% of US stocks
Cheaper than 44% of US stocks
Cheaper than 18% of US stocks
Cheaper than 9% of US stocks
Higher than 74% of US stocks
Higher than 11% of US stocks
Higher than 13% of US stocks
Higher than 60% of US stocks
Higher than 29% of US stocks
Higher than 46% of US stocks
Higher than 57% of US stocks
Higher than 1% of US dividend payers
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
RadNet, Inc. has a market value of $5.8B and an enterprise value of $7.5B.
Revenue in the twelve months to 30 June 2026: $2.3B. The latest quarter grew 25.0% year on year.
Net income over the same four quarters: $19.3M, a 0.8% net margin.
Free cash flow in the twelve months to 30 June 2026: $72.4M.
Trailing P/E: 1425.8×; forward P/E: 90.2× — the forward figure prices analyst consensus estimates, not reported earnings.
Forward dividend yield: 0.00%, paying out 0% of earnings.
RadNet, Inc. employs 11,000 people — $206K of revenue per employee.
Data provided by Twelve Data
The nearest names by industry and size, scored by the same model — like for like.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own RadNet, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
RadNet shares rose 9.7% in the latest session on above-average trading volume. The latest earnings estimate revisions do not suggest further strength ahead.
Why it matters — RDNT watchers may note the recent share-price jump alongside the less supportive earnings estimate revision trend.
Zacks Investment Research says RadNet does not have the combination of two key ingredients associated with a likely earnings beat in its upcoming report. The article focuses on expectations ahead of the report.
Why it matters — RDNT watchers may note the article’s cautious assessment of the likelihood of an earnings beat before the upcoming report.
RadNet announced it will host a conference call to discuss its third-quarter 2026 financial results on November 9, 2026, at 7:30 a.m. Pacific Time (10:30 a.m. Eastern Time).
Why it matters — The call provides RDNT watchers with a scheduled opportunity to hear the company discuss its third-quarter 2026 results.
RadNet said it signed a definitive agreement to acquire ONRAD, a provider of teleradiology and hospital radiology services, in a transaction intended to establish a third operating segment focused on radiology professional services.
Why it matters — The agreement would expand RadNet's operations into radiology professional services and hospital radiology services.
Seeking Alpha published a transcript of a RadNet, Inc. (RDNT) M&A call. The provided excerpt contains no further details about the call.
Why it matters — The transcript is relevant to RDNT watchers interested in the company’s M&A discussions, though the excerpt provides no substantive details.
The 8 Wall Street analysts covering RadNet, Inc. have a median 12-month price target of $96, with estimates ranging from $79 to $105. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Of the 8 analysts covering RadNet, Inc., 8 rate it a Buy, 0 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks RadNet, Inc. 42 out of 100 across roughly 4,600 US stocks as at 4 Nov 2026. None of this is personal advice — it does not consider your circumstances.
As at 4 Nov 2026, RadNet, Inc. ranks 42 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Revisions (73 of 100).
No one can know that. What the data says: the median 12-month target from 8 analysts implies +19.0% from the last close, and Ticker Nerd's factor model ranks RadNet, Inc. 42 out of 100 as at 4 Nov 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
No analyst covering RadNet, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for RDNT are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $79 to $105 over the next 12 months.
RadNet, Inc. returned +2.3% over the 12 months to 4 Nov 2026, with dividends reinvested. Past performance does not indicate future returns.
RadNet Inc. is a healthcare services company that provides outpatient diagnostic imaging services across the United States.
The most recent item we track (Zacks Investment Research, 5 Nov 2026): "RadNet (RDNT) Soars 9.7%: Is Further Upside Left in the Stock?". RadNet shares rose 9.7% in the latest session on above-average trading volume. The latest earnings estimate revisions do not suggest further strength ahead.
RadNet Inc. is a healthcare services company that provides outpatient diagnostic imaging services across the United States. The company operates a large network of fixed-site imaging centers offering services such as MRI, CT, PET, mammography, ultrasound, X-ray, fluoroscopy, and nuclear medicine to support physicians in the diagnosis and treatment of disease. RadNet also develops digital health and radiology technology solutions through its DeepHealth platform, including software and AI-enabled tools designed to improve image interpretation, workflow efficiency, and clinical decision support. Its business is organized around imaging centers and digital health, giving it a role at the intersection of medical diagnostics and healthcare technology. RadNet serves patients, referring physicians, and healthcare providers, with a focus on accessible, high-volume outpatient imaging and radiology informatics.
CEO Dr. Howard G. Berger M.D. · 11,000 employees · United States · https://www.radnet.com
